pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4720 |
Genomic Coordinates | chr16: 81385018 - 81385093 |
Description | Homo sapiens miR-4720 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4720-5p | ||||||||||||||||||||||||
Sequence | 4| CCUGGCAUAUUUGGUAUAACUU |25 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CKAP2L | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | cytoskeleton associated protein 2 like | ||||||||||||||||||||
Transcript | NM_152515 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CKAP2L | |||||||||||||||||||||
3'UTR of CKAP2L (miRNA target sites are highlighted) |
>CKAP2L|NM_152515|3'UTR 1 TTTCTTGATGCTTTTTTTAAAAAAGGTGTTTCAGAACCAACATAAGACAAGAAATATTCTTGTCCAAGTGACCTGGAAAA 81 AAAGAGAGGCATCATGGATGCAGATTATGGACGCTCAGGACTTAAGTAATTCACTGGGCTTACTCTCAAATTTTCTCTCC 161 CCATGGGAAAATCTTTGCTTTATGTGTTTAAGACCAGTTTGCCAGTTTTACAGTATACATAAATTTCAAACTTTTGAATA 241 TTTACCCTACAACTATGATAAATATTTATACTTTATTGATCTACTTTAATCCCAACATAGTTTTTTATATCAGAAGGTTG 321 GTCCCACAATATAATGGGACTTTTCTTTCTGCATCCACCTTAGCAGAGGGCAAGTTCTTTCATCGTGGAAGATCTGAACT 401 TTGACGCTAGCTTGACAGGCTGAATGGACCTTGACAGATGGCCAAGTCAAAACCCCTCATTTTACAGATGAGTTTATGCT 481 AGCTGTGCCTTTGCTCAGAGATCATAAATTTATGTGTGATCTTTGACTTTCATCACAGTATCCTTGTAAATGAGAGAGAA 561 TTCTTGTTTTTTCTATGCCAGGTCTCCTCAGATGAAACACAATCCTGAATTGGCATGGTCGTCTAGCTTTTATATTCAAA 641 CCTAGTTTTGCATTTGTTACTCAGAAACACTTCAAGTAACAAAAGGGGGGCAGGGGAGAGGGGTGGGGAGTGGACACTTG 721 CTTCTTCAGTTCTTTGCTCAGCTAGGGTATAGCTGGCCTGAGAAGGCAGTGCAAGCCCCAGAGACTGTTGTAGGTTGCTT 801 TTTCTTCCTCCTGGGCAACTATTTGTGGAAAGGTTTTACCTTAGTCATTATGTAAATATAATTGTGTAGAAAAACCTAGT 881 CAACACATTTTAAATTTTAGCTTTCTTAATATTTAAGTATTATCTTAAAACAACATTAAATTTCTATTAGTTCCTGCTTG 961 TTTATCTTATTTATTATAGAAAACCATGATAATGGCTTTGCATAGAGAATTAGGAGTTTGTCTAAGGATATACCAGTTGG 1041 CTGTCCTAAGAAACAAGGAGCATTCATTACCAAGGAGAATGGACTTTGATCAAAGGTCTATCAGCCTCATCCAGGAACTA 1121 GATTTTTTTAAGGGAAGCAGATCTATTTCTGAAAGTCAGATTTATAATAAAGCTCAAAAAACTGAGCTATAAACCTGTAA 1201 TACCAGCAGACTTTCAATAAGAGACTCTTACAACTCAATTGTGGAAAAACTAATAATTAAAAATGGGCAAAGGACCTGAG 1281 CAGACATTTCTCCAAAGAAGACATAAGAAATGGCCAGTAGGTATAGATATGAAAAGGTGTTCAGCATCATTAATCATAAG 1361 AATAATGTAAATTAAAACCACTGTGAGCTATCACCTCACATCTATAAGAATGGCTATTAACAAGACATGAGATAAATGTT 1441 GATGAGATTGTGGAGAAAAGAGAACCCTAGTACACTGTTTGTGGGCGTGTAGACTGGGGCAGCCGTTATGGAAAACGGTA 1521 TGGAGGCTCCTAAAGAAATTAAAAATAGAACTGTTATCTGACCCTCTTCTGAGTAAGTATGTACCCAAAGAAGATGAAAT 1601 CACCAGCTGGGCGCAGTGACTCACACCTGTAATCCCAGCACTTTGGAGTGGGTGAATCACCTGAGGTCAGGAGTTCAAGA 1681 CCAGCTTGACCAACATGGTGAAACCCCGTCTCTACTAAAAATACAAAAAGTAGGCGGGCATGGTGACGGGCACCTGTAAT 1761 CCCAGCTACTTGGGAGGCTGAGGCAGAAGAATCACTTGAACTCGGGAGGTGGAGGTTGCAGTGAGCCAAAATTGCGTCAC 1841 TGCACTCCAGCCTGGGTTACAGAGCAAGACTCCATCTCAAAAAAAAAAAAGATGAAATCATCACCTCATAAAGATATCTG 1921 CACTCACATGTTTGTGGCAGTGTTATTCTCAATAGCCAAGATGTGGAAACAACCTAAATGCCCATCAATGGACAAATAAA 2001 GAAAATACGGCATATGCATGCCGTGGAATAGTATTCATCCTTGGAAAAGAGGGAGTTCTTGCCATTTGCCACAACATAGA 2081 TGGACCTGGAGAACATTATGCTAAGTGAAATAAGCCAGACCCAAGGAAAAATACTGCATGATCTCACATATGGAATATTT 2161 AATTTTTTAAGAAAGAGCTCAAGTACACAGAGAAAGTGCTTACCACAGATTGGGGAAGAGGAAATGGGGAGATGCAGGCC 2241 AAGGATACAAAATAGCAGATAAAATGAACAAGTCTAGAGATAGGGCTAAAGTTAATACAATTGTATTAGGGATTTTTGTT 2321 AAATAAGTAGATTTTAGCTGCTATTATCACAAAAAAACTGAGATGATAATGTTAATCTGCTTCACTATAGCAGCCATTTT 2401 ATTATCTATATGTATCCCATAACATCATGTTGTAAATCTTAAATATACCTAATAAAATAAAATTGTCACCAAAAAAAAAA 2481 AAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000541405.1 | 3UTR | UUUUUUCUAUGCCAGGUCUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
40 hsa-miR-4720-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT064869 | ZBTB18 | zinc finger and BTB domain containing 18 | 2 | 2 | ||||||||
MIRT099937 | SOX4 | SRY-box 4 | 2 | 2 | ||||||||
MIRT204534 | SLC39A10 | solute carrier family 39 member 10 | 2 | 4 | ||||||||
MIRT221679 | ZNRF2 | zinc and ring finger 2 | 2 | 2 | ||||||||
MIRT296659 | MRGBP | MRG domain binding protein | 2 | 6 | ||||||||
MIRT331634 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 2 | 2 | ||||||||
MIRT337078 | RER1 | retention in endoplasmic reticulum sorting receptor 1 | 2 | 2 | ||||||||
MIRT497580 | PTCHD4 | patched domain containing 4 | 2 | 2 | ||||||||
MIRT498838 | NAPEPLD | N-acyl phosphatidylethanolamine phospholipase D | 2 | 4 | ||||||||
MIRT502561 | EBAG9 | estrogen receptor binding site associated, antigen, 9 | 2 | 2 | ||||||||
MIRT508128 | AMD1 | adenosylmethionine decarboxylase 1 | 2 | 2 | ||||||||
MIRT511875 | GOLGA7 | golgin A7 | 2 | 6 | ||||||||
MIRT512924 | UBL4A | ubiquitin like 4A | 2 | 2 | ||||||||
MIRT513833 | KLHL15 | kelch like family member 15 | 2 | 6 | ||||||||
MIRT515889 | FAM182B | family with sequence similarity 182 member B | 2 | 2 | ||||||||
MIRT520201 | WASL | Wiskott-Aldrich syndrome like | 2 | 2 | ||||||||
MIRT526045 | GMDS | GDP-mannose 4,6-dehydratase | 2 | 2 | ||||||||
MIRT533601 | TNPO1 | transportin 1 | 2 | 2 | ||||||||
MIRT535539 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | 2 | 6 | ||||||||
MIRT541150 | PABPC1 | poly(A) binding protein cytoplasmic 1 | 2 | 4 | ||||||||
MIRT549609 | TMEM101 | transmembrane protein 101 | 2 | 2 | ||||||||
MIRT552630 | ZBTB41 | zinc finger and BTB domain containing 41 | 2 | 2 | ||||||||
MIRT555503 | PNISR | PNN interacting serine and arginine rich protein | 2 | 2 | ||||||||
MIRT560225 | PCNA | proliferating cell nuclear antigen | 2 | 2 | ||||||||
MIRT561671 | RAPGEF2 | Rap guanine nucleotide exchange factor 2 | 2 | 2 | ||||||||
MIRT562103 | ITGB1 | integrin subunit beta 1 | 2 | 2 | ||||||||
MIRT570710 | E2F3 | E2F transcription factor 3 | 2 | 2 | ||||||||
MIRT570802 | CKAP2L | cytoskeleton associated protein 2 like | 2 | 2 | ||||||||
MIRT615261 | DPF2 | double PHD fingers 2 | 2 | 2 | ||||||||
MIRT615389 | ZNF747 | zinc finger protein 747 | 2 | 2 | ||||||||
MIRT616621 | KCNJ11 | potassium voltage-gated channel subfamily J member 11 | 2 | 4 | ||||||||
MIRT641085 | ZKSCAN2 | zinc finger with KRAB and SCAN domains 2 | 2 | 2 | ||||||||
MIRT654971 | PLEKHA2 | pleckstrin homology domain containing A2 | 2 | 2 | ||||||||
MIRT667033 | PDE3A | phosphodiesterase 3A | 2 | 2 | ||||||||
MIRT677217 | RASSF6 | Ras association domain family member 6 | 2 | 2 | ||||||||
MIRT699243 | SLC6A8 | solute carrier family 6 member 8 | 2 | 2 | ||||||||
MIRT711673 | TRMT5 | tRNA methyltransferase 5 | 2 | 2 | ||||||||
MIRT713922 | CACNA2D1 | calcium voltage-gated channel auxiliary subunit alpha2delta 1 | 2 | 2 | ||||||||
MIRT722736 | BRMS1 | breast cancer metastasis suppressor 1 | 2 | 2 | ||||||||
MIRT724997 | CDC27 | cell division cycle 27 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|